Dhiraj Kumar

2.0k total citations
28 papers, 1.3k citations indexed

About

Dhiraj Kumar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dhiraj Kumar has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Dhiraj Kumar's work include Cancer-related molecular mechanisms research (7 papers), Cancer Cells and Metastasis (6 papers) and Bone and Dental Protein Studies (3 papers). Dhiraj Kumar is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Cancer Cells and Metastasis (6 papers) and Bone and Dental Protein Studies (3 papers). Dhiraj Kumar collaborates with scholars based in United States, India and China. Dhiraj Kumar's co-authors include Gopal C. Kundu, Amit Singh Yadav, Ramesh Butti, Vinoth Prasanna Gunasekaran, Mahadeo Gorain, Sumit Das, Santosh Kumar, Gautam Kundu, Poonam R. Pandey and Totakura V. S. Kumar and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dhiraj Kumar

28 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dhiraj Kumar 735 423 409 200 98 28 1.3k
Zhinong Jiang 892 1.2× 337 0.8× 425 1.0× 231 1.2× 147 1.5× 71 1.6k
Ramesh Butti 545 0.7× 352 0.8× 315 0.8× 113 0.6× 90 0.9× 19 921
Angélica Figueroa 1.2k 1.6× 439 1.0× 559 1.4× 100 0.5× 146 1.5× 46 1.7k
Rosa Puca 837 1.1× 552 1.3× 392 1.0× 110 0.6× 63 0.6× 31 1.3k
Lavinia Nardinocchi 702 1.0× 549 1.3× 365 0.9× 143 0.7× 59 0.6× 20 1.1k
Jury Gladkich 1.0k 1.4× 724 1.7× 643 1.6× 137 0.7× 134 1.4× 32 1.6k
Duc‐Hiep Bach 810 1.1× 303 0.7× 494 1.2× 111 0.6× 140 1.4× 21 1.2k
Huiling Yang 1.3k 1.8× 475 1.1× 542 1.3× 150 0.8× 148 1.5× 65 1.7k
Oriol de Barrios 917 1.2× 562 1.3× 398 1.0× 174 0.9× 139 1.4× 14 1.4k

Countries citing papers authored by Dhiraj Kumar

Since Specialization
Citations

This map shows the geographic impact of Dhiraj Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dhiraj Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dhiraj Kumar more than expected).

Fields of papers citing papers by Dhiraj Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dhiraj Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dhiraj Kumar. The network helps show where Dhiraj Kumar may publish in the future.

Co-authorship network of co-authors of Dhiraj Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Dhiraj Kumar. A scholar is included among the top collaborators of Dhiraj Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dhiraj Kumar. Dhiraj Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mondal, Jayanta, Junfeng Zhang, Shunping Li, et al.. (2025). Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche. Nature Communications. 16(1). 1378–1378. 4 indexed citations
2.
Patel, Bhakti, Yifan Zhou, Feiyang Ma, et al.. (2024). STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response. Leukemia. 38(5). 1143–1155. 2 indexed citations
3.
Banerjee, Ananya, S Anupriya, Dhiraj Kumar, et al.. (2022). Antiproliferative and Apoptotic Potential of Methotrexate Lipid Nanoparticles in A Murine Breast Cancer Model. Nanomedicine. 17(11). 753–764. 5 indexed citations
4.
Yadav, Amit Singh, Totakura V. S. Kumar, Anuradha Bulbule, et al.. (2022). Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway. Cancer Cell International. 22(1). 122–122. 99 indexed citations
5.
Pandey, Poonam R., Ken H. Young, Dhiraj Kumar, & Neeraj Jain. (2022). RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics. Molecular Cancer. 21(1). 58–58. 66 indexed citations
6.
Butti, Ramesh, Gautam Kundu, Anuradha Bulbule, et al.. (2021). Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression. Oncogene. 40(11). 2002–2017. 62 indexed citations
7.
Yadav, Amit Singh, et al.. (2019). Non-coding RNAs as potential therapeutic targets in breast cancer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1863(4). 194378–194378. 67 indexed citations
8.
Kumar, Dhiraj, Saikat Haldar, Mahadeo Gorain, et al.. (2018). Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway. BMC Cancer. 18(1). 52–52. 56 indexed citations
9.
Yadav, Amit Singh, Poonam R. Pandey, Ramesh Butti, et al.. (2018). The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation. Frontiers in Oncology. 8. 72–72. 45 indexed citations
10.
Butti, Ramesh, Sumit Das, Vinoth Prasanna Gunasekaran, et al.. (2018). Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Molecular Cancer. 17(1). 34–34. 276 indexed citations
11.
Kumar, Dhiraj, Mahadeo Gorain, Gautam Kundu, & Gopal C. Kundu. (2017). Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma. Molecular Cancer. 16(1). 7–7. 58 indexed citations
12.
Chen, Luxi, et al.. (2017). Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer. Bioorganic & Medicinal Chemistry Letters. 28(3). 420–424. 7 indexed citations
13.
Ghosh, Alip, Debanjali Dasgupta, Amit Ghosh, et al.. (2017). MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. Cell Death and Disease. 8(3). e2706–e2706. 130 indexed citations
14.
Dai, Xiaoyun, Kwang Seok Ahn, Ling Zhi Wang, et al.. (2016). Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 15(12). 2966–2976. 82 indexed citations
15.
Kumar, Dhiraj, Santosh Kumar, Mahadeo Gorain, et al.. (2016). Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis. Journal of Investigative Dermatology. 136(12). 2462–2474. 62 indexed citations
16.
Kumar, Dhiraj, et al.. (2014). The potential of class 3 semaphorins as both targets and therapeutics in cancer. Expert Opinion on Therapeutic Targets. 19(3). 427–442. 10 indexed citations
17.
Kumar, Santosh, Priyanka Sharma, Dhiraj Kumar, et al.. (2013). Functional Characterization of Stromal Osteopontin in Melanoma Progression and Metastasis. PLoS ONE. 8(7). e69116–e69116. 34 indexed citations
18.
Bursavich, Matthew G., Mark D. Shenderovich, Kraig M. Yager, et al.. (2013). Novel Mps1 kinase inhibitors: From purine to pyrrolopyrimidine and quinazoline leads. Bioorganic & Medicinal Chemistry Letters. 23(24). 6829–6833. 13 indexed citations
19.
Kumar, Santosh, Priyanka Sharma, Dhiraj Kumar, et al.. (2012). Andrographolide Inhibits Osteopontin Expression and Breast Tumor Growth Through Down Regulation of PI3 Kinase/Akt Signaling Pathway. Current Molecular Medicine. 12(8). 952–966. 54 indexed citations
20.
Williams, Brandi L., Daniel Cimbora, Vijay Baichwal, et al.. (2009). Abstract #LB-204: MPI-0479605: A novel small molecule inhibitor of the mitotic kinase TTK with anti-tumor activity in pre-clinical models. Cancer Research. 69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhinong Jiang Breakdown of academic impact, for papers by Ramesh Butti Breakdown of academic impact, for papers by Angélica Figueroa Breakdown of academic impact, for papers by Rosa Puca Breakdown of academic impact, for papers by Lavinia Nardinocchi Breakdown of academic impact, for papers by Jury Gladkich Breakdown of academic impact, for papers by Duc‐Hiep Bach Breakdown of academic impact, for papers by Huiling Yang Breakdown of academic impact, for papers by Oriol de Barrios
Rankless by CCL
2026